WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 10 fonti

Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Raccontata da

sciencedaily.com

independent.co.uk

theguardian.com

newsbytesapp.com

channelnewsasia.com

medpagetoday.com

sciencealert.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

theguardian.comStai leggendo1 mesi fa

Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

Timeline cronologica

lunedì 1 giugno 2026·sciencedaily.com
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.…
lunedì 1 giugno 2026·independent.co.uk
Weight loss drugs could widen health inequalities, experts warn
Researchers argue the long-term benefits of weight loss jabs depend on nutrition advice and support

newsbytesapp.com

1 mesi fa

Weight loss drugs can protect you from breast cancer

Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

Leggi questa versione → originale

dailymail.com1 mesi fa

Weight-loss jabs could cut breast cancer risk by nearly a third

Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

Leggi questa versione → originale

independent.co.uk1 mesi fa

GLP-1s may lower breast cancer risk in women by 30%, new study suggests

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity (Alamy/PA) (Alamy/PA)A new study from the…

Leggi questa versione → originale

euronews.com1 mesi fa

Weight-loss drugs linked to lower breast cancer risk, study finds

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.

Leggi questa versione → originale

channelnewsasia.com1 mesi fa

GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit.

Leggi questa versione → originale

martedì 2 giugno 2026·

theguardian.com

Weight-loss drugs can cut breast cancer risk by up to 30%, studies suggest

Three studies add to evidence that jabs could be part of cancer-fighting toolkit to cut risk of developing or dying from disease

martedì 2 giugno 2026·

dailymail.com

Weight-loss jabs could cut breast cancer risk by nearly a third

Weight loss jabs could significantly lower the risk of breast cancer , even in those considered at high risk of the disease, a landmark study has suggested.

martedì 2 giugno 2026·

independent.co.uk

Women on GLP-1 drugs 30 percent less likely to develop breast cancer

About 42,140 women are expected to die from breast cancer in the U.S. this year

martedì 2 giugno 2026·

independent.co.uk

GLP-1s may lower breast cancer risk in women by 30%, new study suggests

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleWeight-loss jabs have risen in popularity…

mercoledì 3 giugno 2026·

newsbytesapp.com

Weight loss drugs can protect you from breast cancer

Weight-loss drugs may reduce breast cancer risk by up to 30%, according to three studies, highlighting their potential role in lowering cancer development and mortality rates.

mercoledì 3 giugno 2026·

abcnews.com

Doctor breaks down study showing GLP-1s may lower breast cancer risk

A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.

giovedì 4 giugno 2026·

channelnewsasia.com

GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer

More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm…

giovedì 4 giugno 2026·

euronews.com

Weight-loss drugs linked to lower breast cancer risk, study finds

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study.

giovedì 4 giugno 2026·

medpagetoday.com

Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention

Use of drugs for overweight/obesity linked to lower risk of breast cancer, several leukemias

venerdì 5 giugno 2026·

sciencealert.com

Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer

The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.